Quironsalud Madrid
Larynx cancer treatment cost in Spain typically starts with essential diagnostics like a PET/CT scan ranging from $1,300 to $1,800. Primary surgical interventions such as a laryngectomy run from $18,000 to $30,000, while laser surgery for laryngeal cancer costs between $12,000 and $16,000. Total expenses depend on the tumor stage and chosen technology. Patients often find 30-50% savings compared to US healthcare prices. Barcelona and Madrid remain the premier destinations for oncology.
Typical Larynx Cancer Treatment Costs in Spain
Bookimed Expert Insight: Early-stage patients should prioritize centers offering organ-preserving laser surgeries. Hospital Quiron Barcelona provides advanced robotized surgery and PET-CT staging, supporting 40,000 patients annually. For complex cases, Clinica Universidad de Navarra offers JCI-accredited care with high success rates. Patients seeking innovative research may find value at Quironsalud Madrid, which conducts active cancer clinical trials.
| Turkey | Austria | Spain | |
| Throat cancer operation | from $9,000 | from $30,000 | from $22,500 |
| Radiotherapy for throat cancer | from $3,250 | from $7,038 | from $4,103 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,790 |
| Laser surgery for laryngeal cancer | from $7,000 | from $15,000 | from $12,000 |
| Chemotherapy for larynx cancer | from $5,000 | from $12,000 | from $4,000 |
Dr. López-Ibor specializes in pediatric hematology and oncology, with over 32 years of experience of experience treating bone and brain tumors.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor is responsible for thoracic malignancy management and oversees thoracic cancer trials at the Oncology Department. Their research focuses on optimizing chemotherapy in early-stage disease, evaluating new therapies, exploring pharmacogenomic approaches, integrating immunotherapy for lung cancer, and investigating resistance mechanisms to tyrosine-kinase inhibitors.
Holding a medical degree and a PhD in medical oncology from UAB, the doctor is a member of several prestigious oncology societies, including ESMO, ASCO, and IASLC. They have published numerous peer-reviewed articles and book chapters on thoracic malignancies and have held teaching positions at UAB and UVicc-UCC.